1.
Tolerability and Efficacy of Apixaban Versus Rivaroxaban for Non-Valvular Atrial Fibrillation. mfm [Internet]. 2024 Apr. 7 [cited 2025 Nov. 16];33(3). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/586